Issued Patents All Time
Showing 26–50 of 64 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 9359437 | Antibodies comprising chimeric constant domains | Eric Smith, Supriya Patel | 2016-06-07 |
| 9309326 | Readily isolated bispecific antibodies with native immunoglobulin format | Eric Smith, Douglas MacDonald, Kara Olson | 2016-04-12 |
| 9139644 | Modified chimeric polypeptides with improved pharmacokinetic properties | Nicholas J. Papadopoulos, George D. Yancopoulos | 2015-09-22 |
| 8647842 | Methods for producing a fusion protein capable of binding VEGF | Nicholas J. Papadopoulos, George D. Yancopoulos | 2014-02-11 |
| 8586713 | Readily isolated bispecific antibodies with native immunoglobulin format | Eric Smith, Douglas MacDonald, Kara Olson | 2013-11-19 |
| 8343737 | Cell culture compositions capable of producing a VEGF-binding fusion polypeptide | Nicholas J. Papadopoulos, George D. Yancopoulos | 2013-01-01 |
| 8084234 | Isolated nucleic acid molecules encoding a fusion protein capable of binding VEGF | Nicholas J. Papadopoulos, George D. Yancopoulos | 2011-12-27 |
| 8029791 | Modified chimeric polypeptides with improved pharmacokinetic properties | Nicholas J. Papadopoulos, George D. Yancopoulos | 2011-10-04 |
| 7964377 | Nucleic acid molecule encoding a fusion polypeptide capable of binding VEGF | Nicholas J. Papadopoulos, George D. Yancopoulos | 2011-06-21 |
| 7704500 | Methods of inhibiting ascites formation with modified chimeric VEGF polypeptides | Nicholas J. Papadopoulos, George D. Yancopoulos | 2010-04-27 |
| 7524499 | Modified chimeric polypeptides with improved pharmacokinetic properties | Nicholas J. Papadopoulos, George D. Yancopoulos | 2009-04-28 |
| 7374758 | Modified chimeric polypeptides with improved pharmacokinetic properties and methods of using thereof | Nicholas J. Papadopoulos, George D. Yancopoulos | 2008-05-20 |
| 7374757 | Modified chimeric polypeptides with improved pharmacokinetic properties | Nicholas J. Papadopoulos, George D. Yancopoulos | 2008-05-20 |
| 7205148 | Genome mutation by intron insertion into an embryonic stem cell genome | Aris N. Economides, David M. Valenzuela, George D. Yancopoulos | 2007-04-17 |
| 7070959 | Modified chimeric polypeptides with improved pharmacokinetic properties | Nicholas J. Papadopoulos, George D. Yancopoulos | 2006-07-04 |
| 7063840 | TIE-2 ligands, methods of making and uses thereof | Joanne Bruno, Mitchell Goldfarb, Thomas H. Aldrich, Peter C. Maisonpierre, Czeslaw Radziejewski +2 more | 2006-06-20 |
| 7063965 | Nucleic acid encoding TIE-2 ligand | George D. Yancopoulos | 2006-06-20 |
| 7045302 | Expressed ligand-vascular intercellular signaling molecule | George D. Yancopoulos | 2006-05-16 |
| 7008781 | Method of enhancing the biological activity of ligands | Nicholas Gale, George D. Yancopoulos, Neil Stahl | 2006-03-07 |
| 6825008 | Expressed ligand—vascular intercellular signalling molecule | George D. Yancopoulos | 2004-11-30 |
| 6645484 | Method of blocking blood vessel growth using tie-2 ligand 2 | Joanne Bruno, Mitchell Goldfarb, Thomas H. Aldrich, Peter C. Maisonpierre, Czeslaw Radziejewski +2 more | 2003-11-11 |
| 6627415 | TIE-2 ligands, methods of making and uses thereof | George D. Yancopoulos | 2003-09-30 |
| 6602683 | Biologically active Eph family ligands | Nicholas Gale, George D. Yancopoulos | 2003-08-05 |
| 6441137 | Expressed ligand-vascular intercellular signalling molecule | George D. Yancopoulos | 2002-08-27 |
| 6433143 | Tie-2 ligands | Joanne Bruno, Mitchell Goldfarb, Thomas H. Aldrich, Peter C. Maisonpierre, Czeslaw Radziejewski +2 more | 2002-08-13 |